Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder-Preliminary Results of the PROVIT Study.

Nutrients. 2020;12(9)
Full text from:

Plain language summary

Major depressive disorder (MDD) is a disease with multiple aetiology and symptoms that can end in death due to suicide. A biological imbalance in free radicals and inflammatory molecules have been associated with depression and diseases such as obesity which are often associated with MDD. Probiotics may potentially be able to redress this imbalance through several mechanisms. The aim of this randomised placebo-controlled trial was to assess the effect of probiotics on mood, brain function, gut microbiome and inflammation genes in 61 individuals with MDD over 4 weeks. The results showed that probiotic intake improved expression of some but not all of the assessed inflammatory genes and it was concluded that positive effects of probiotics on inflammation may mean that they are of benefit to those with MDD. This study could be used by healthcare professionals who are looking at additional, non-pharmacological ways of supporting patients with MDD.

Abstract

Major depressive disorder (MDD) is a prevalent disease, in which one third of sufferers do not respond to antidepressants. Probiotics have the potential to be well-tolerated and cost-efficient treatment options. However, the molecular pathways of their effects are not fully elucidated yet. Based on previous literature, we assume that probiotics can positively influence inflammatory mechanisms. We aimed at analyzing the effects of probiotics on gene expression of inflammation genes as part of the randomized, placebo-controlled, multispecies probiotics PROVIT study in Graz, Austria. Fasting blood of 61 inpatients with MDD was collected before and after four weeks of probiotic intake or placebo. We analyzed the effects on gene expression of tumor necrosis factor (TNF), nuclear factor kappa B subunit 1 (NFKB1) and interleukin-6 (IL-6). In IL-6 we found no significant main effects for group (F(1,44) = 1.33, p = ns) nor time (F(1,44) = 0.00, p = ns), but interaction was significant (F(1,44) = 5.67, p < 0.05). The intervention group showed decreasing IL-6 gene expression levels while the placebo group showed increasing gene expression levels of IL-6. Probiotics could be a useful additional treatment in MDD, due to their anti-inflammatory effects. Results of the current study are promising, but further studies are required to investigate the beneficial effects of probiotic interventions in depressed individuals.

Lifestyle medicine

Patient Centred Factors : Mediators/Major depressive disorder
Environmental Inputs : Microorganisms ; Mind and spirit
Personal Lifestyle Factors : Psychological
Functional Laboratory Testing : Blood
Bioactive Substances : Probiotics

Methodological quality

Jadad score : 3
Allocation concealment : No

Metadata

Nutrition Evidence keywords : Major depressive disorder ; MDD ; Inflammation ; Microbiome